Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 102944

In scope icon M 11 E
QID 102944 (Type "102944" in App Search)
A 28-year-old woman presents to the emergency department with the complaint of double vision. She experienced a similar episode one year ago that has since resolved. Two years ago she had transient gait instability that also resolved. In between these episodes, she has maintained near-normal functioning. She sees a neurologist who prescribes interferon-beta in an effort to decrease the frequency of these events. Which of the following should this patient be counseled of regarding this medication?

Avoid exposure to sunlight without sunscreen as she is at increased risk of sunburning

0%

0/0

She should be on contraceptives if she is currently or will be sexually active, as this drug is teratogenic

0%

0/0

She should be screened regularly for serum lipid abnormalities and glucose resistance

0%

0/0

She is at increased risk of osteoporosis

0%

0/0

She should increase the folate intake in her diet

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient's history of neurologic deficits separated by both time and space with a return to baseline in between is consistent with relapsing-remitting multiple sclerosis (RRMS). Interferon-beta, used in the treatment of RRMS, is a known teratogen and women should be started on contraceptives if prescribed this medication.

Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system resulting in episodic neurologic dysfunction that often recovers. There are four major classes of MS: RRMS, secondary progressive MS, primary progressive MS, and benign MS. MS affects twice as many women as men.

Saguil et al. report that symptom exacerbations are seen in approximately 85% of patients with MS. Corticosteroids are used in the acute setting to relieve symptoms. They note that disease-modifying agents should be initiated early in MS to delay disease progression and preserve function. Current immunomodulatory agents used include interferon beta and glatiramer, as well as five immunosuppressive agents, fingolimod, teriflunomide, dimethyl fumarate, natalizumab, and mitoxantrone.

Goodin et al. in the American Academy of Neurology's report on disease-modifying therapies for MS, summarize the available evidence for IFN-beta in the treatment of RRMS. They assert that there is Class I evidence that treatment with IFN-beta delays the development of clinically definite MS by delaying the time between attacks 2 and 3 or between attacks 3 and 4. They caution though that studies do not show that early treatment affects long-term disability outcome.

Incorrect Answers:
Answer 1: Tetracyclines are a common cause of photosensitivity.
Answer 3: Atypical antipsychotics are a common cause of lipid and glucose abnormalities.
Answer 4: Long-term corticosteroid use is a common cause of drug-induced osteoporosis.
Answer 5: Phenytoin is a common cause of folate deficiency.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

3.8

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(4)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options